Pubblicazioni

Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group – ESOI Joint Paper

2022 - FRONTIERS IN ONCOLOGY
Fournier, L.; de Geus-Oei, L. -F.; Regge, D.; Oprea-Lager, D. -E.; D'Anastasi, M.; Bidaut, L.; Bauerle, T.; Lopci, E.; Cappello, G.; Lecouvet, F.; Mayerhoefer, M.; Kunz, W. G.; Verhoeff, J. J. C.; Caruso, D.; Smits, M.; Hoffmann, R. -T.; Gourtsoyianni, S.; Beets-Tan, R.; Neri, E.; deSouza, N. M.; Deroose, C. M.; Caramella, C.

Sequential dual-phase cone-beam CT is able to intra-procedurally predict the one-month treatment outcome of multi-focal HCC, in course of degradable starch microsphere TACE

2019 - LA RADIOLOGIA MEDICA
Lucatelli, P.; De Rubeis, G.; Basilico, F.; Ginanni Corradini, L.; Corona, M.; Bezzi, M.; Catalano, C.

RECIST 1.1 criteria predict recurrence-free survival in advanced ovarian cancer submitted to neoadjuvant chemotherapy

2019 - EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY
Bogani, G; Matteucci, L; Tamberi, S; Ditto, A; Sabatucci, I; Murgia, F; Arcangeli, V; Maltese, G; Comerci, G; Stefanetti, M; Sonetto, C; Calareso, G; Marchiano, A; Chiappa, V; Lorusso, D; Raspagliesi, F.

Efficacy of Vandetanib in treating locally advanced or metastatic medullary thyroid carcinoma according to RECIST Criteria. A systematic review and meta-analysis

2018 - FRONTIERS IN ENDOCRINOLOGY
Trimboli, P.; Castellana, M.; Virili, C.; Giorgino, F.; Giovanella, L.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma